These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 5652572)
1. Biologic properties of skin test antigens of yeast form Sporotrichum schenckii. Nielsen HS J Infect Dis; 1968 Apr; 118(2):173-80. PubMed ID: 5652572 [No Abstract] [Full Text] [Related]
2. Cell wall proteins of Sporothrix schenckii as immunoprotective agents. Alba-Fierro CA; Pérez-Torres A; López-Romero E; Cuéllar-Cruz M; Ruiz-Baca E Rev Iberoam Micol; 2014; 31(1):86-9. PubMed ID: 24257472 [TBL] [Abstract][Full Text] [Related]
3. Immune Response Induced by an Immunodominant 60 kDa Glycoprotein of the Cell Wall of Sporothrix schenckii in Two Mice Strains with Experimental Sporotrichosis. Alba-Fierro CA; Pérez-Torres A; Toriello C; Pulido-Camarillo E; López-Romero E; Romo-Lozano Y; Gutiérrez-Sánchez G; Ruiz-Baca E J Immunol Res; 2016; 2016():6525831. PubMed ID: 27051673 [TBL] [Abstract][Full Text] [Related]
4. Skin test and blastogenic responses to Sporotrichun schenckii. Steele RW; Cannady PB; Moore WL; Gentry LO J Clin Invest; 1976 Jan; 57(1):156-60. PubMed ID: 1107353 [TBL] [Abstract][Full Text] [Related]
5. A cell wall protein-based vaccine candidate induce protective immune response against Sporothrix schenckii infection. Portuondo DL; Batista-Duharte A; Ferreira LS; Martínez DT; Polesi MC; Duarte RA; de Paula E Silva AC; Marcos CM; Almeida AM; Carlos IZ Immunobiology; 2016 Feb; 221(2):300-9. PubMed ID: 26547105 [TBL] [Abstract][Full Text] [Related]
6. Detection of 2 immunoreactive antigens in the cell wall of Sporothrix brasiliensis and Sporothrix globosa. Ruiz-Baca E; Hernández-Mendoza G; Cuéllar-Cruz M; Toriello C; López-Romero E; Gutiérrez-Sánchez G Diagn Microbiol Infect Dis; 2014 Jul; 79(3):328-30. PubMed ID: 24827145 [TBL] [Abstract][Full Text] [Related]
7. Delayed hypersensitivity cross-reactions between Sporothrix schenckii and Ceratocystis species in sporotrichotic patients. Ishizaki H; Nakamura Y; Kariya H; Iwatsu T; Wheat R J Clin Microbiol; 1976 Jun; 3(6):545-7. PubMed ID: 59734 [TBL] [Abstract][Full Text] [Related]
8. Detection of cellular immunity with the soluble antigen of the fungus Sporothrix schenckii in the systemic form of the disease. Carlos IZ; Sgarbi DB; Angluster J; Alviano CS; Silva CL Mycopathologia; 1992 Mar; 117(3):139-44. PubMed ID: 1640975 [TBL] [Abstract][Full Text] [Related]
9. The immune response against Candida spp. and Sporothrix schenckii. Martínez-Álvarez JA; Pérez-García LA; Flores-Carreón A; Mora-Montes HM Rev Iberoam Micol; 2014; 31(1):62-6. PubMed ID: 24252829 [TBL] [Abstract][Full Text] [Related]
10. Dendritic cell are able to differentially recognize Sporothrix schenckii antigens and promote Th1/Th17 response in vitro. Verdan FF; Faleiros JC; Ferreira LS; Monnazzi LG; Maia DC; Tansine A; Placeres MC; Carlos IZ; Santos-Junior RR Immunobiology; 2012 Aug; 217(8):788-94. PubMed ID: 22656886 [TBL] [Abstract][Full Text] [Related]
11. Proteomics-Based Characterization of the Humoral Immune Response in Sporotrichosis: Toward Discovery of Potential Diagnostic and Vaccine Antigens. Rodrigues AM; Fernandes GF; Araujo LM; Della Terra PP; dos Santos PO; Pereira SA; Schubach TM; Burger E; Lopes-Bezerra LM; de Camargo ZP PLoS Negl Trop Dis; 2015; 9(8):e0004016. PubMed ID: 26305691 [TBL] [Abstract][Full Text] [Related]
12. [A comparative study of the polysaccharides produced by the fungi "Ceratocystis stenoceras" and "Sporothrix schenckii". Chemical nature and immunological properties (author's transl)]. Toriello C; Mariat F Ann Microbiol (Paris); 1974 Apr; 125A(3):287-307. PubMed ID: 4214190 [No Abstract] [Full Text] [Related]
13. Sporothrix schenckii lipid inhibits macrophage phagocytosis: involvement of nitric oxide and tumour necrosis factor-alpha. Carlos IZ; Sgarbi DB; Santos GC; Placeres MC Scand J Immunol; 2003 Mar; 57(3):214-20. PubMed ID: 12641649 [TBL] [Abstract][Full Text] [Related]
14. Current research on the immune response to experimental sporotrichosis. Carlos IZ; Sassá MF; da Graça Sgarbi DB; Placeres MC; Maia DC Mycopathologia; 2009 Jul; 168(1):1-10. PubMed ID: 19241140 [TBL] [Abstract][Full Text] [Related]
15. The predominance of alternatively activated macrophages following challenge with cell wall peptide-polysaccharide after prior infection with Sporothrix schenckii. Alegranci P; de Abreu Ribeiro LC; Ferreira LS; Negrini Tde C; Maia DC; Tansini A; Gonçalves AC; Placeres MC; Carlos IZ Mycopathologia; 2013 Aug; 176(1-2):57-65. PubMed ID: 23686275 [TBL] [Abstract][Full Text] [Related]
16. Antigenic structures of Sporothrix schenckii. Travassos LR Immunol Ser; 1989; 47():193-221. PubMed ID: 2484980 [No Abstract] [Full Text] [Related]
18. Sporotrichosis between 1898 and 2017: The evolution of knowledge on a changeable disease and on emerging etiological agents. Lopes-Bezerra LM; Mora-Montes HM; Zhang Y; Nino-Vega G; Rodrigues AM; de Camargo ZP; de Hoog S Med Mycol; 2018 Apr; 56(suppl_1):126-143. PubMed ID: 29538731 [TBL] [Abstract][Full Text] [Related]
19. Sporothrix schenckii complex and sporotrichosis, an emerging health problem. López-Romero E; Reyes-Montes Mdel R; Pérez-Torres A; Ruiz-Baca E; Villagómez-Castro JC; Mora-Montes HM; Flores-Carreón A; Toriello C Future Microbiol; 2011 Jan; 6(1):85-102. PubMed ID: 21162638 [TBL] [Abstract][Full Text] [Related]
20. Role of TLR-2 and fungal surface antigens on innate immune response against Sporothrix schenckii. Negrini Tde C; Ferreira LS; Alegranci P; Arthur RA; Sundfeld PP; Maia DC; Spolidorio LC; Carlos IZ Immunol Invest; 2013; 42(1):36-48. PubMed ID: 23231043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]